Bayer Consumer Health is ramping up its Latin and North America supply capacity with a MXN$1.1bn ($52m) investment in its Mexican production site.
Bayer Consumer Health Expands North America And LATAM Supply Capacity
Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.
